Skip to main content
PerMed

EU-Africa PerMed announces its 2nd Stakeholder Workshop

PerMedThe South African Medical Research Council (SAMRC) through the Europe-Africa Personalised Medicine (EU- Africa PerMed) consortium is hosting the second stakeholder workshop taking place on 20-21 February 2023 in Cape Town, South Africa. The event has attracted 80-100 registered key representatives from Africa and Europe.

The EU-Africa PerMed project sets to build links between Europe and Africa in Personalised Medicine (PM) and has initiated several core stakeholder engagement initiatives from February 2022 to January 2023. These workshops allowed discussions on the perception of PM, the main challenges and opportunities of PM in Africa and potential advantages of a closer collaboration with Europe in integrating local knowledge and practice. In-depth regional engagements followed across the African continent, as a mode for understanding the potential to develop PM in Africa on various levels. This may include developing the PM agenda by building collaborations, structuring platforms, and scientific hubs, strengthening regulatory frameworks and developing regional strategies. Therefore, the second stakeholder workshop will provide an opportunity to reflect on the findings from these activities to:

  • Review the PM landscape in Africa from various regional outcomes.
  • Validate and refinement of areas of mutual interest between Africa and Europe.
  • Validating the gaps and needs identified for developing areas of interest.
  • The importance and understanding of models of collaboration with the EU.
  • Reflect on models of collaboration for developing PM in the different regions (governance, funding, partnerships, training program, etc.).
  • Understand the challenges and opportunities for collaboration with Europe.

What is Personalised Medicine?

Personalised Medicine (PM) is a medical model that is used to characterise an individuals’ phenotype and genotype (e.g., molecular and genetic profiling, medical imaging, and lifestyle data), to tailor the right therapeutic strategy for the right person at the right time, and/or to determine the predisposition to disease, and/or to deliver timely and targeted prevention. Ultimately, personalised medicine aims to provide more precise and effective medical care to individuals, as opposed to a “one-size-fits-all” approach, with the goal of improving patient outcomes and overall health.

NOTE TO EDITORS

Additional information on the project is available here: https://www.euafrica-permed.eu

For more enquires:

  1. Ms Rizwana Mia
    Senior Program Manager- Grants Innovation and Product Development
    Email: Rizwana.Mia@mrc.ac.za
    Mobile: 084 257 7230
  2. Ms Yolanda Phakela
    Public Relations Manager
    Email: Yolanda.Phakela@mrc.ac.za
    Cell: 073 801 3691
Release date
SDG3
EU-Africa
Personalised Medicine
Equitable healthcare
Collaboration

Press release archives